These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32598747)

  • 1. [Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection].
    Maev IV; Andreev DN; Kucheryavyy YA; Shaburov RI
    Ter Arkh; 2019 Aug; 91(8):4-11. PubMed ID: 32598747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Esophagoprotective therapy in patients with erosive esophagitis].
    Bakulina NV; Tikhonov SV; Topalova YG; Ilchishina TA; Vasiliev RV
    Ter Arkh; 2022 Oct; 94(8):985-991. PubMed ID: 36286979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials].
    Bordin DS; Andreev DN; Maev IV
    Ter Arkh; 2023 Jan; 94(12):1407-1412. PubMed ID: 37167186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extraesophageal signs of gastroesophageal reflux disease: otorhinolaryngologist's view].
    Radtsig EY; Konstantinov DI
    Ter Arkh; 2021 Apr; 93(4):521-525. PubMed ID: 36286791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
    Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection and regeneration of esophageal, pharyngeal, and laryngeal mucosa as a major element in therapy of patients with esophageal and extraesophageal reflux symptoms.
    Gąsiorowska A
    Otolaryngol Pol; 2020 Aug; 74(4):40-45. PubMed ID: 32909960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.
    Kasugai K; Ogasawara N
    Intern Med; 2024 Jan; 63(1):1-10. PubMed ID: 36927966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial.
    Kakushima N; Hori K; Ono H; Horimatsu T; Uedo N; Ohata K; Doyama H; Kaneko K; Oda I; Hikichi T; Kawahara Y; Niimi K; Takaki Y; Mizuno M; Yazumi S; Hosokawa A; Imagawa A; Niimi M; Yoshimura K; Muto M
    J Gastroenterol; 2016 Feb; 51(2):104-11. PubMed ID: 25940151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
    Frazzoni L; Fuccio L; Frazzoni M
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy.
    Borbély Y; Bouvy N; Schulz HG; Rodriguez LA; Ortiz C; Nieponice A
    Surg Obes Relat Dis; 2018 May; 14(5):611-615. PubMed ID: 29567054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
    Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
    J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
    Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
    Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
    Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.